Category: BioMarin
Achondroplasia
BioMarin
Novel therapy improves height for children with achondroplasia
via Healio/Endocrine Today Children with a common form of skeletal dysplasia saw persistent and sustained improvements in annualized growth... Read MoreBioMarin
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
Achondroplasia
Ascendis
BioMarin
Pfizer
QED
Prospects for Pharmaceutical Treatment of Achondroplasia
BioMarin
Hypochondroplasia
Skeletal Dysplasia
Study may change treatment of childhood growth disorders
Achondroplasia
BioMarin
BioMarin – Update for Achondroplasia Associations
As more cases of COVID-19 are confirmed, we recognize the increased challenges and concerns faced by participants in the... Read More